FDA grants Breakthrough Therapy to oral infigratinib for children with achondroplasia
FDA grants Breakthrough Therapy to oral infigratinib for children with achondroplasia | Image Credit: © Araki Illustrations - © Araki Illustrations - stock.adobe.com.The FDA...
New Combination Treatment Brings Hope to Patients
Newswise — Findings from the international FORT-2 clinical trial showed that a combination treatment including immunotherapy is safe and tolerable in patients with locally...
Highlights from ESMO 2024: Key Oncology Advances from Major Pharmaceutical Companies
ESMO 2024: advanced ADCs, KEYTRUDA updates, predictive biomarkers for NSCLC, ADCs developments and new treatments for melanoma.
Source link
Bladder Cancer Breakthroughs in SunRISe-1, AMBASSADOR, and VOLGA Trials
Read the Full Video TranscriptAlicia Morgans: Hi. I'm so excited to be here today with Professor Maria De Santis, who is joining me to...
